TY  - JOUR
AU  - Vitalle, Joana
AU  - Terren, Iñigo
AU  - Gamboa-Urquijo, Leire
AU  - Orrantia, Ane
AU  - Tarancon-Diez, Laura
AU  - Genebat, Miguel
AU  - Ruiz-Mateos, Ezequiel
AU  - Leal, Manuel
AU  - Garcia-Obregon, Susana
AU  - Zenarruzabeitia, Olatz
AU  - Borrego, Francisco
PY  - 2018
DO  - 10.3389/fimmu.2018.01709
SN  - 1664-3224
UR  - http://hdl.handle.net/10668/12809
T2  - Frontiers in immunology
AB  - The ability of the CD300a inhibitory receptor to modulate immune cell functions and its involvement in the pathogenesis of many diseases has aroused a great interest in this molecule. Within human CD4+ T lymphocytes from healthy donors, the inhibitory...
LA  - en
PB  - Frontiers Research Foundation
KW  - CD300
KW  - CD300a
KW  - CD4 T cells
KW  - PD1
KW  - human immunodeficiency virus-1
KW  - Humans
KW  - HIV Infections
KW  - CD4-Positive T-Lymphocytes
KW  - HIV-1
KW  - HIV Seropositivity
KW  - Receptors, Cell Surface
KW  - Disease Progression
TI  - Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.
TY  - research article
VL  - 9
ER  -